OTCMFLHLF
Market cap8mUSD
Jan 10, Last price
0.03USD
1D
-17.57%
1Q
-6.45%
IPO
-89.39%
Name
Filament Health Corp
Chart & Performance
P/E
—
P/S
5.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
2m
+484.63%
Net income
-5m
L-67.68%
CFO
-4m
L+8.30%
Profile
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 2,131 484.63% | 364 | ||
Cost of revenue | 6,318 | 5,678 | ||
Unusual Expense (Income) | ||||
NOPBT | (4,187) | (5,314) | ||
NOPBT Margin | ||||
Operating Taxes | (71) | |||
Tax Rate | ||||
NOPAT | (4,187) | (5,243) | ||
Net income | (5,322) -67.68% | (16,466) 77.95% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 3,350 | 1,250 | ||
BB yield | ||||
| Debt | ||||
Debt current | 160 | 123 | ||
Long-term debt | 1,709 | 1,665 | ||
Deferred revenue | 201 | |||
Other long-term liabilities | ||||
Net debt | (1,410) | (1,058) | ||
| Cash flow | ||||
Cash from operating activities | (4,188) | (3,867) | ||
CAPEX | (58) | (32) | ||
Cash from investing activities | (58) | (71) | ||
Cash from financing activities | 3,227 | 2,155 | ||
FCF | (4,004) | (4,762) | ||
| Balance | ||||
Cash | 1,828 | 2,847 | ||
Long term investments | 1,450 | |||
Excess cash | 3,172 | 2,829 | ||
Stockholders' equity | (3,109) | (1,156) | ||
Invested Capital | 7,259 | 5,603 | ||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 187,682 | 169,647 | ||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | (3,979) | (5,113) | ||
EV/EBITDA | ||||
Interest | 375 | 185 | ||
Interest/NOPBT | ||||